On 22 May, European Patent court at the Hague overturned Benitec’s cardinal DNA-directed RNA patent for the European Union. Benitec will hereafter have to pay to use Mick Graham’s work in the EU, and there will not get exclusive rights to it.
It would be difficult to convey concisely how disappointing and bad this is for Benitec shareholders, especially in view of other events taking place. This event is very counter to guidance previously given by Benitec management, who have stated that Benitec’s global patent estate was secure. Since the
… Read more